Godrej Properties’ ‘Breathe a Little Deeper’ Panel Sparks Dialogue on Wellness by Design
Experts and industry leaders discuss wellness-focused living at Godrej South EstateOutdoor AQI…
Picarro Achieves ISO/IEC 27001:2022, 27017, and 27018 Certifications and Successfully Completes SOC 2 Type 2 Examination
Compliance with Rigorous International Standards Ensure Picarro Meets the Highest Levels of…
Euroclear builds on strong momentum in Q3 2025
BRUSSELS, Oct. 24, 2025 /PRNewswire/ -- Results for the first nine months…
Milliken & Company Launches Millad ClearX 9000: The Clear Choice for Polypropylene
Delivers exceptional clarity with lower additive levels, streamlining production and expanding formulation…
London School Joins Always Active Uniform Pilot to Combat Childrens Inactivity and Obesity Levels
Wednesday 1 October, 2025 Reception pupils at Harbinger Primary School received free…
C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting
September 20, 2025 11:00 ET | Source: C4 Therapeutics, Inc. Cemsidomide in…
Myriad Genetics Announces Precise MRD Clinical Data Published in The Lancet Oncology
SALT LAKE CITY, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc.,…
WuXi Biologics Launches HEK 293 Stable Cell Line Platform WuXia293 Stable for Development and Manufacturing of Difficult-to-Express Molecules
WuXia293Stable platform demonstrates high titer, human glycosylation and improved product quality by eliminating…
Manipal Hospital Yeshwanthpur Leads the Charge as Heart Attacks in Young Indians Reach Crisis Levels
BENGALURU, India, July 17, 2025 /PRNewswire/ -- India is witnessing an alarming…
AVEROA receives European marketing authorization for XOANACYL, an Oral Therapy for Chronic Kidney Disease (CKD)
XOANACYL is an oral therapy designed to address critical challenges in CKD,…